{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:34:17Z","timestamp":1761518057169},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1097\/qai.0b013e3182986fc6","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T18:41:26Z","timestamp":1371062486000},"page":"S200-S207","source":"Crossref","is-referenced-by-count":9,"title":["Antiretroviral Therapy for Prevention of HIV and Tuberculosis"],"prefix":"10.1097","volume":"63","author":[{"given":"Margaret L.","family":"McNairy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa M.","family":"El-Sadr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":". Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-16-20210131","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":". Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R3-16-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":". Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"R4-16-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":". Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"R6-16-20210131","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/cis203","article-title":"Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.","volume":"54","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R7-16-20210131","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1377\/hlthaff.2012.0250","article-title":". HIV treatment as prevention: how scientific discovery occurred and translated rapidly into policy for the global response.","volume":"31","author":"Cohen","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"R8-16-20210131","doi-asserted-by":"crossref","first-page":"21271","DOI":"10.1073\/pnas.1209017110","article-title":"Economics of antiretroviral treatment vs. circumcision for HIV prevention.","volume":"109","author":"Barnighausen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-16-20210131","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5588\/ijtld.10.0483","article-title":". Antiretroviral therapy and the control of HIV-associated tuberculosis.","volume":"15","author":"Lawn","year":"2011","journal-title":"Will ART do it Int J Tuberc Lung Dis"},{"key":"R10-16-20210131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200401020-00010","article-title":". Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.","volume":"18","author":"Porco","year":"2004","journal-title":"AIDS"},{"key":"R12-16-20210131","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(10)60936-1","article-title":". Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.","volume":"376","author":"Montaner","year":"2010","journal-title":"Lancet"},{"key":"R13-16-20210131","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1086\/422601","article-title":". Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan.","volume":"190","author":"Fang","year":"2004","journal-title":"J Infect Dis"},{"key":"R14-16-20210131","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.1228160","article-title":". High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.","volume":"339","author":"Tanser","year":"2013","journal-title":"Science"},{"key":"R15-16-20210131","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1001\/archinte.1994.00420170123012","article-title":". Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.","volume":"154","author":"Musicco","year":"1994","journal-title":"Arch Intern Med"},{"key":"R16-16-20210131","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":". Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.","volume":"375","author":"Donnell","year":"2010","journal-title":"Lancet"},{"key":"R18-16-20210131","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/OLQ.0b013e31817e2491","article-title":". Sexual transmission of HIV-1 among serodiscordant couples in Porto Alegre, southern Brazil.","volume":"35","author":"Melo","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R21-16-20210131","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/QAI.0b013e3181e9b6b7","article-title":". HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China.","volume":"55","author":"Lu","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-16-20210131","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","article-title":". Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.","volume":"373","author":"Granich","year":"2009","journal-title":"Lancet"},{"key":"R25-16-20210131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001247","article-title":"HIV treatment as prevention: modelling the cost of antiretroviral treatmentstate of the art and future directions.","volume":"9","author":"Meyer-Rath","year":"2012","journal-title":"PLoS Med"},{"key":"R26-16-20210131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001263","article-title":"HIV treatment as prevention: issues in economic evaluation.","volume":"9","author":"Barnighausen","year":"2012","journal-title":"PLoS Med"},{"key":"R27-16-20210131","article-title":"HIV treatment as prevention: models, data, and questionstowards evidence-based decision-making.","volume":"9","year":"2012","journal-title":"PLoS Med"},{"key":"R29-16-20210131","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(95)90519-7","article-title":". Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote dIvoire.","volume":"345","author":"Ackah","year":"1995","journal-title":"Lancet"},{"key":"R30-16-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","article-title":"Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa.","volume":"15","author":"Mukadi","year":"2001","journal-title":"AIDS"},{"key":"R31-16-20210131","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":". Timing of initiation of antiretroviral drugs during tuberculosis therapy.","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"R32-16-20210131","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":". Survival rate and risk factors of mortality among HIVtuberculosis-coinfected patients with and without antiretroviral therapy.","volume":"43","author":"Manosuthi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-16-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31819367e7","article-title":". Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.","volume":"50","author":"Velasco","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-16-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0b013e318177594e","article-title":". Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand.","volume":"48","author":"Sanguanwongse","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R35-16-20210131","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R36-16-20210131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":". Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"key":"R37-16-20210131","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":". The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"R38-16-20210131","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":". 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"},{"key":"R39-16-20210131","doi-asserted-by":"crossref","first-page":"933","DOI":"10.5588\/ijtld.10.0666","article-title":". Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi.","volume":"15","author":"Zachariah","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"R40-16-20210131","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/QAI.0b013e31820413b3","article-title":". Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.","volume":"56","author":"Middelkoop","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R41-16-20210131","doi-asserted-by":"crossref","first-page":"19485","DOI":"10.1073\/pnas.1005660107","article-title":". Antiretroviral therapy for tuberculosis control in nine African countries.","volume":"107","author":"Williams","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R42-16-20210131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMoa0910370","article-title":". Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.","volume":"363","author":"Severe","year":"2010","journal-title":"N Engl J Med"},{"key":"R43-16-20210131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/157016211798038524","article-title":"Antiretroviral treatment as prevention: impact of the test and treat strategy on the tuberculosis epidemic.","volume":"9","author":"Wood","year":"2011","journal-title":"Curr HIV Res"},{"key":"R45-16-20210131","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201004-0598OC","article-title":". Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township.","volume":"182","author":"Middelkoop","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R47-16-20210131","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMp1300458","article-title":"When to start ART in Africaan urgent research priority.","volume":"368","author":"De Cock","year":"2013","journal-title":"N Engl J Med"},{"key":"R49-16-20210131","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/QAD.0b013e3283543e83","article-title":". Antiviral agents and HIV prevention: controversies, conflicts, and consensus.","volume":"26","author":"Cohen","year":"2012","journal-title":"AIDS"},{"key":"R51-16-20210131","first-page":"359","article-title":"Hoffman S, et al..","volume":"24","author":"Lahuerta","year":"2013","journal-title":"The problem of late ART initiation in sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon J Health Care Poor Underserved"},{"key":"R53-16-20210131","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2105\/AJPH.92.3.388","article-title":". Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco.","volume":"92","author":"Katz","year":"2002","journal-title":"Am J Public Health"},{"key":"R57-16-20210131","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/QAD.0b013e328355d67b","article-title":"The HIV care continuum: no partial credit given.","volume":"26","author":"McNairy","year":"2012","journal-title":"AIDS"},{"key":"R58-16-20210131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001056","article-title":"Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.","volume":"8","author":"Rosen","year":"2011","journal-title":"PLoS Med"},{"key":"R60-16-20210131","first-page":"1618","article-title":"Vital signs: HIV prevention through care and treatmentUnited States.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R61-16-20210131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciq243","article-title":". The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.","volume":"52","author":"Gardner","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R63-16-20210131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":". Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"R65-16-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":". Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"R68-16-20210131","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/QAI.0b013e3182354e65","article-title":". Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings.","volume":"58","author":"Bitega","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R70-16-20210131","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":". Preexposure prophylaxis for HIV infection among African women.","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"R73-16-20210131","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(06)69117-4","article-title":"Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study.","volume":"368","author":"Badri","year":"2006","journal-title":"Lancet"},{"key":"R74-16-20210131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1086\/426827","article-title":". How soon after infection with HIV does the risk of tuberculosis start to increase A retrospective cohort study in South African gold miners.","volume":"191","author":"Sonnenberg","year":"2005","journal-title":"J Infect Dis"},{"key":"R75-16-20210131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":". Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources.","volume":"10","author":"Lawn","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"suppl 2","key":"R77-16-20210131","first-page":"S61","article-title":"Game changers: why did the scale-up of HIV treatment work despite weak health systems J Acquir Immune Defic Syndr.","volume":"57","author":"De Cock","year":"2011","journal-title":""},{"key":"R83-16-20210131","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.280.1.78","article-title":". Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.","volume":"280","author":"Carpenter","year":"1998","journal-title":"JAMA"},{"key":"R84-16-20210131","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/jama.1997.03540480062040","article-title":". Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.","volume":"277","author":"Carpenter","year":"1997","journal-title":"JAMA"},{"key":"R85-16-20210131","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1996.03540020068031","article-title":". Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.","volume":"276","author":"Carpenter","year":"1996","journal-title":"JAMA"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e3182986fc6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:01:58Z","timestamp":1620972118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201307012-00016"}},"subtitle":["A Promising Intervention but Not a Panacea"],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":55,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3182986fc6","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}